William Auger, MD, dispels the myth that pulmonary thromboendarterectomy (PTE, also known as PEA) cannot be performed in older patients.
Richard Channick, MD, dispels the myth that PTE/PEA is still an experimental technique in CTEPH.
Nick H. Kim, MD, dispels the myth that very ill patients cannot be considered for pulmonary thromboendarterectomy surgery, the only potentially curative treatment for CTEPH.
Paul Forfia, MD, dispels the myth that the ventilation/perfusion scan is contraindicated in patients who have pulmonary hypertension.
William Auger, MD, dispels the myth that pulmonary thromboendarterectomy surgery has a high mortality rate.
Paul Forfia, MD, dispels the myth that PVR >1000 dyn•sec•cm-5 makes a patient ineligible for PTE.
Victor F. Tapson, MD, dispels the myth that PTE/PEA surgery can’t be done in obese patients.
Ivan Robbins, MD, dispels the myth that a ventilation/perfusion scan showing perfusion defects is sufficient to diagnose CTEPH.
Richard Channick, MD, dispels the myth that medical therapy can be used to delay or replace PTE surgery.
Victor F. Tapson, MD, dispels the myth that a patient who recovers from an acute pulmonary embolism cannot go on to develop CTEPH.
Nick H. Kim, MD, dispels the myth that computerized tomographic pulmonary angiography can be used as a screen instead of a V/Q scan to rule out CTEPH.
Ivan Robbins, MD, dispels the myth that once PH is confirmed by RHC, there is no need to perform a V/Q scan.